Nutra Pharma Corp (NPHC) financial statements (2021 and earlier)

Company profile

Business Address 12538 W. ATLANTIC BLVD.
CORAL SPRINGS, FL 33071
State of Incorp. CA
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 00000
Cash and cash equivalents 00000
Receivables000000
Inventory, net of allowances, customer advances and progress billings00000(0)
Inventory00000(0)
Prepaid expense  000
Prepaid expense and other current assets0
Other undisclosed current assets0000 0
Total current assets:000000
Noncurrent Assets
Property, plant and equipment000000
Other noncurrent assets00000
Prepaid expense and other noncurrent assets0
Total noncurrent assets:000000
TOTAL ASSETS:000000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:220022
Accounts payable111111
Accrued liabilities111111
Employee-related liabilities  1   
Taxes payable  1   
Other undisclosed accounts payable and accrued liabilities  (4)(2)  
Debt111022
Derivative instruments and hedges, liabilities00    
Due to related parties 001  
Other undisclosed current liabilities323310
Total current liabilities:654444
Noncurrent Liabilities
Long-term debt and lease obligation   1  
Long-term debt, excluding current maturities   1  
Liabilities, other than long-term debt   1  
Due to related parties   1  
Other undisclosed noncurrent liabilities 00(2)  
Total noncurrent liabilities: 000  
Total liabilities:654444
Stockholders' equity
Stockholders' equity attributable to parent(5)(4)(4)(4)(4)(4)
Preferred stock0     
Common stock200111
Additional paid in capital504946393734
Accumulated deficit(57)(53)(50)(45)(42)(38)
Total stockholders' equity:(5)(4)(4)(4)(4)(4)
TOTAL LIABILITIES AND EQUITY:000000

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues000100
Revenue, net 00100
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)(0)(0)
Other undisclosed gross profit (0)    
Gross profit:0(0)0000
Operating expenses(1)(2)(6)(5)(5)(5)
Other undisclosed operating income   323
Operating loss:(1)(2)(6)(2)(2)(3)
Nonoperating income (expense) 00(0)(2)(1)
Investment income, nonoperating 0 0(1)(0)
Other nonoperating income (expense)  0(0)0 
Interest and debt expense(0)(0)(0)(0)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(2)(2)(6)(3)(5)(4)
Other undisclosed income (loss) from continuing operations before income taxes(2)(1)001 
Loss from continuing operations before income taxes:(4)(3)(5)(3)(4)(4)
Income tax expense (benefit)(2)101  
Loss before gain (loss) on sale of properties:(6)(2)(5)(2)(4)(4)
Other undisclosed net income (loss)2(1)(0)   
Net loss:(4)(3)(5)(2)(4)(4)
Other undisclosed net income (loss) attributable to parent   (1) 1
Net loss available to common stockholders, diluted:(4)(3)(5)(3)(4)(4)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(4)(3)(5)(2)(4)(4)
Comprehensive loss, net of tax, attributable to parent:(4)(3)(5)(2)(4)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: